Foundayo is a once-daily oral GLP-1 tablet containing the active ingredient orforglipron.
Treatment starts with a low dose and is increased gradually. This gives your body time to adjust to the medicine and can help reduce gastrointestinal side effects such as nausea, vomiting and diarrhoea.
Weight Loss Service
Start your weight loss journey with professional support from Chemist Click
Check EligibilityThe Foundayo starting dose is 0.8mg once daily for at least 30 days.
This is the lowest available strength and is used to introduce the medicine gradually.
After at least 30 days, the licensed schedule says the dose should be increased to 2.5mg once daily.
Starting with a low dose helps the body adjust to Foundayo and is intended to reduce the likelihood and severity of gastrointestinal side effects.
These can include:
You should not start Foundayo at a higher dose unless specifically instructed to do so by your prescriber.
Further reading: Foundayo side effects
After taking Foundayo 0.8mg once daily for at least 30 days, the next dose is:
Foundayo 2.5mg once daily.
After at least another 30 days on 2.5mg, the dose may be increased to 5.5mg once daily.
From this point, further increases to 9mg, 14.5mg and 17.2mg are based on:
There is therefore no requirement for every patient to progress all the way to 17.2mg.
Foundayo does not have one single maintenance dose that is suitable for everyone.
Once you have progressed beyond the initial doses, your treatment can be adjusted according to how well it is working and how well you tolerate it.
Potential ongoing doses include:
You do not need to keep increasing the dose simply because a higher strength is available.
For example, if your current dose is producing a satisfactory response and you are tolerating it well, your prescriber may decide that there is no need to increase it immediately.
Equally, if the response is insufficient and the medicine is well tolerated, increasing to the next dose may be considered.
The highest dose of Foundayo is 17.2mg once daily.
In clinical trials, Foundayo 17.2mg helped people lose around 12.4% of their starting body weight over 72 weeks and 15% after 36 weeks.
Further reading: Orforglipron results
Some medicines can affect how orforglipron is processed in the body. If you are taking medication that interacts with orforglipron, your prescriber may limit your dose to a maximum of 9mg once daily.
The dose of Foundayo is increased monthly. You will need to have taken it for at least 30 days, before increasing the dose.
Some people may need to stay on their current dose for longer to give their body more time to adjust before moving up. If you reach a dose that is helping to control your appetite and support weight loss, there may be no need to increase further. For many people, this is often seen from the 9mg dose onwards.
A simple way to think about it is:
| Month | Daily dose |
|---|---|
| Month 1 | 0.8mg once daily |
| Month 2 | 2.5mg once daily |
| Month 3 | 5.5mg once daily |
| Month 4 | 9mg once daily if needed and tolerated |
| Month 5 | 14.5mg once daily if needed and tolerated |
| Month 6 | 17.2mg once daily if needed and tolerated |
Important note
There must be at least 30 days between Foundayo dose increases.
Foundayo is started on a low introductory dose to help your body get used to the medicine and reduce the risk of side effects.
This first dose is not where the best weight loss results are usually seen. The stronger effects tend to come at the higher doses, which is why the dose is increased gradually over time.
Some people do notice good appetite suppression on lower doses and may choose to stay there, but overall, higher doses are more likely to produce greater weight loss.
Foundayo is increased gradually mainly to help improve tolerability.
GLP-1 receptor agonists commonly cause gastrointestinal side effects, particularly when treatment is first started or the dose is increased.
These can include:
Moving through the doses gradually gives your body more time to adapt.
Increasing Foundayo faster than recommended does not necessarily mean you will lose weight faster and may increase the likelihood of side effects.
Further reading: Foundayo side effects
No. Not everyone taking Foundayo needs to reach 17.2mg.
The aim is not simply to reach the highest possible dose.
After the early stages of treatment, the dose is adjusted according to response and tolerability.
Some people may achieve an appropriate treatment response at a lower dose, while others may need to gradually move through the higher strengths.
The right dose is therefore individual rather than automatically being 17.2mg for everyone.
If you miss a dose of Foundayo, take it as soon as you remember. Do not take two doses together or double up your next dose.
If you have missed 7 or more days in a row, you may need to restart on a lower dose and increase gradually again to help reduce the risk of side effects. If this happens, speak to your prescriber or pharmacist for advice.
Foundayo’s dosing schedule is designed to help your body build up tolerance gradually, especially before moving to the higher doses, which are generally linked with greater average weight loss.
That does not mean everyone will need the highest dose. Some people may find that a lower dose is already helping to reduce appetite and support weight loss, and in those cases, it may be appropriate to stay there rather than keep increasing.
In practice, this should be an individualised decision made with your doctor or pharmacist, based on how well the medicine is working for you and how well you are tolerating it.
No. Foundayo is designed to be taken once daily, not every other day. The prescribing information says to take it orally once a day and not to take more than one tablet per day.
Foundayo can be taken with or without food.
There is no single best time of day to take orforglipron. The main thing is to take it once a day at a time you can stick to consistently.
Generally, higher doses tend to lead to greater average weight loss, which is why the dose is increased gradually over time. In the ATTAIN-1 trial, the highest dose produced the greatest average weight loss, although individual response can vary and some people do well on lower doses.
Increasing too quickly can make side effects more likely, especially stomach-related symptoms such as nausea, vomiting, diarrhoea, indigestion, abdominal pain and bloating.
The official dosing schedule is designed to reduce this risk by stepping up gradually.
Yes. Dose increases are based on treatment response and tolerability, so if side effects are bothering you, it may make sense to stay on your current dose for longer before moving up.
If you are struggling with side effects, you should speak to your prescriber or pharmacist before increasing further. They may advise you to stay on your current dose longer, or in some cases review whether the medicine is still suitable for you.
In practice, if a dose is not suiting you, your prescriber may decide that reducing to a lower dose is the safest option.
No. You should not increase Foundayo earlier than the licensed dosing schedule because you are not losing weight quickly enough.
You should remain on each dose for at least 30 days before a dose increase is considered.
Foundayo is a long-term weight-management medicine, and the early doses are part of the gradual titration process.
Not seeing substantial weight loss during the first few weeks does not necessarily mean that treatment will not work for you.
Yes, depending on your treatment response and tolerability, your prescriber may decide that you should remain on a lower dose rather than immediately increasing it.
After the early dose-escalation period, Foundayo dosing is individualised.
There is no requirement for every patient to progress to the maximum 17.2mg dose.
Whilst all of our content is written and reviewed by healthcare professionals, it is not intended to be substituted for or used as medical advice. If you have any questions or concerns about your health, please speak to your doctor.